Jan-2022
Hyivy Health secures $1.1 million in pre-seed funding to ease women’s pelvic health problems
Born from its founder’s own experience with cervical cancer, FemTech startup Hyivy Health has secured $1.1 million in pre-seed funding to improve womens’ pelvic health.
Threshold Impact, Beresford Ventures, Equation Angels, Zambon Research Venture, The51, OCI, iGan, and Velocity all participated in the oversubscribed round, along with a number of individual angel investors. The round closed in December.
Hyivy Health is developing the first smart, holistic pelvic health rehabilitation product for the one in three women who will develop pelvic health complications in their lifetime.
The startup has ambitious plans for its new capital. Hyivy Health plans to use the funds to help with manufacturing of its device, safety testing, certification, and to move through regulatory approvals with the FDA and Health Canada.
It plans to complete an upcoming clinical trial in May 2022 with McMaster University to further explore the device’s use for pelvic pain with endometriosis patients and tracking chronic pelvic pain.
Read the full Betakit article here